Incidence and timing of recurrences of sudden death and ventricular tachycardia during antiarrhythmic drug treatment after myocardial infarction

Am J Cardiol. 1992 Jun 1;69(17):1403-6. doi: 10.1016/0002-9149(92)90890-b.

Abstract

Incidence and timing of recurrences of sustained ventricular tachycardia (VT) or sudden death were studied in 206 patients who survived their first episode of ventricular fibrillation (VF; n = 52) or sustained VT (n = 154) after myocardial infarction. All patients were treated with (empirically selected) antiarrhythmic drugs; 49% received amiodarone. After a mean follow-up of 36 months, 64 patients (41%) in the VT group and 10 (19%) in the VF group had nonfatal VT recurrences. Sudden death occurred in 22 (14%) and 9 (17%) patients in the VT and VF groups, respectively. Incidence of sudden death had 2 peaks at approximately 3 and 12 months. Nonfatal VT recurrences were more frequent (most often occurring in first 6 months) in the VT than in the VF group. Sudden death occurred during the following 3 years in only 10% of patients who survived 1 year. There was a much higher incidence of sudden death in patients with left ventricular ejection fraction (LVEF) less than or equal to 40% than in those with LVEF greater than 40% (28 of 65 vs 3 of 141; p less than 0.0001), but no relation between LVEF and nonfatal VT recurrences.

MeSH terms

  • Aged
  • Anti-Arrhythmia Agents / therapeutic use*
  • Death, Sudden, Cardiac / etiology*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Myocardial Infarction / complications*
  • Recurrence
  • Retrospective Studies
  • Tachycardia / drug therapy*
  • Tachycardia / etiology
  • Time Factors
  • Ventricular Fibrillation / drug therapy
  • Ventricular Fibrillation / etiology

Substances

  • Anti-Arrhythmia Agents